A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarker...

por Freedman, OC, Amir, E, Dranitsaris, G, Dowsett, M, Cole, DEC, Kahn, H, O'Malley, F, Verma, S, Clemons, M
Publicado 2009

Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer

por Hanna, W., O’Malley, F.P., Barnes, P., Berendt, R., Gaboury, L., Magliocco, A., Pettigrew, N., Robertson, S., Sengupta, S., Têtu, B., Thomson, T.
Publicado 2007

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers

por Schrader, K A, Masciari, S, Boyd, N, Salamanca, C, Senz, J, Saunders, D N, Yorida, E, Maines-Bandiera, S, Kaurah, P, Tung, N, Robson, M E, Ryan, P D, Olopade, O I, Domchek, S M, Ford, J, Isaacs, C, Brown, P, Balmana, J, Razzak, A R, Miron, P, Coffey, K, Terry, M B, John, E M, Andrulis, I L, Knight, J A, O'Malley, F P, Daly, M, Bender, P, Moore, R, Southey, M C, Hopper, J L, Garber, J E, Huntsman, D G
Publicado 2010